Dementia with lewy bodies patients with high tau levels display unique proteome profiles
2024

Unique Proteome Profiles in Dementia with Lewy Bodies Patients with High Tau Levels

Sample size: 59 publication 10 minutes Evidence: moderate

Author Information

Author(s): Greally Sinead, Kumar Mukesh, Schlaffner Christoph, van der Heijden Hanne, Lawton Elisabeth S., Biswas Deeptarup, Berretta Sabina, Steen Hanno, Steen Judith A.

Primary Institution: F.M. Kirby Neurobiology Center, Department of Neurobiology, Boston Children’s Hospital, Harvard Medical School

Hypothesis

The study investigates the molecular interplay between tau and α-synuclein in patients with Dementia with Lewy Bodies (DLB).

Conclusion

The study found distinct proteome profiles in DLB patients with high tau levels, suggesting a continuum of neurodegenerative diseases.

Supporting Evidence

  • DLBTau+ patients showed increased levels of tau and other proteins compared to controls.
  • Distinct phosphorylation and ubiquitination patterns were observed between DLBTau+ and DLBTau− groups.
  • Proteomic analysis revealed significant upregulation of proteins involved in cytokine signaling and metabolic pathways.

Takeaway

Researchers looked at brain samples from people with a type of dementia and found that those with more tau protein had different protein patterns than those with less tau.

Methodology

Quantitative mass spectrometry was used to analyze protein abundance in brain tissue from DLB patients and controls.

Potential Biases

Potential bias in patient selection and the retrospective nature of the study.

Limitations

The study is limited by the small sample size of DLB subgroups and the reliance on post-mortem tissue.

Participant Demographics

30 DLB patients and 29 age-matched controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13024-024-00782-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication